| Structure |
Chemical Name |
CAS |
MF |
 |
DEXTROMETHORPHAN IMPURITY A |
58496-77-8 |
C17H24BrNO |
 |
クリンダマイシンB |
18323-43-8 |
C17H31ClN2O5S |
 |
Benazepril EP Impurity D |
112110-48-2 |
C24H28N2O5 |
 |
2-cyanoethyl 3-aminobut-2-enoate |
193539-61-6 |
C7H10N2O2 |
 |
Bromhexine Glucose Compound 1 |
3049873-97-1 |
C20H30Br2N2O5 |
 |
Ozagrel |
78712-80-8 |
C15H16N2O2 |
![N-(2-Amino-2-oxoethyl)-N-[(2S)-2-(3,5-dioxo-1-piperazinyl)propyl]-glycine](/CAS/20180703/GIF/120418-76-0.gif) |
N-(2-Amino-2-oxoethyl)-N-[(2S)-2-(3,5-dioxo-1-piperazinyl)propyl]-glycine |
120418-76-0 |
C11H18N4O5 |
 |
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyraMide |
198470-82-5 |
C20H20N2O4S |
![α-[(Z)-メトキシイミノ]-2-フラン酢酸](/CAS/GIF/39684-61-2.gif) |
α-[(Z)-メトキシイミノ]-2-フラン酢酸 |
39684-61-2 |
C7H7NO4 |
 |
RebaMipide 3-Chloro IMpurity |
90098-05-8 |
C19H15ClN2O4 |
 |
3-Dechloro-3-broMo Trazodone Hydrochloride |
1263278-80-3 |
C19H23BrClN5O |
 |
3'-デメチル-12-デオキシエリスロマイシン |
33442-56-7 |
C36H65NO12 |
 |
Teriflunomide Impurity 1 |
1385789-70-7 |
C12H12N2O2 |
 |
6-Des(diethanolamino)-6-chloro Dipyridamole |
54093-92-4 |
C20H30ClN7O2 |
 |
Dapagliflozin Impurity 27 |
|
|
![2-[[(3,5-DiMethyl-2-pyridinyl)Methyl]thio]-6-Methoxy-1H-benziMidazole](/CAS/GIF/704910-89-4.gif) |
2-[[(3,5-DiMethyl-2-pyridinyl)Methyl]thio]-6-Methoxy-1H-benziMidazole |
704910-89-4 |
C16H17N3OS |
 |
Dapagliflozin Impurity 8 |
2305949-33-9 |
C15H12ClIO2 |
 |
Erlotinib Impurity 48 |
2304005-44-3 |
C8H8BrN |
 |
Pitavastatin |
154170-27-1 |
C32H36FNO4 |
 |
Cephalexin IMpurity C |
|
C16H17N3O4S |
 |
Lapatinib 4-Fluoro Impurity |
1026818-86-9 |
C29H26ClFN4O4S |
 |
プロリルラパマイシン |
156223-31-3 |
C50H77NO13 |
 |
Tetrabenazine Related Impurity 3 |
19328-35-9 |
C19H27NO3 |
![2,2'-(disulfanediylbis(methylene))bis(1-(5-methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethylpyridin-4(1H)-one)](/CAS/20210111/GIF/1803449-02-6.gif) |
2,2'-(disulfanediylbis(methylene))bis(1-(5-methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethylpyridin-4(1H)-one) |
1803449-02-6 |
C32H32N6O4S2 |
 |
Flomoxef Impurity III |
|
|
 |
シンバスタチンヒドロキシ酸エチルエステル |
864357-87-9 |
C27H44O6 |
![1-(2,6-difluorobenzyl)-1H-[1,2,3]triazole-4-carboxylic acid ethyl ester](/CAS/20200331/GIF/869501-51-9.gif) |
1-(2,6-difluorobenzyl)-1H-[1,2,3]triazole-4-carboxylic acid ethyl ester |
869501-51-9 |
C12H11F2N3O2 |
![(6R,6β)-3-[(アセチルオキシ)メチル]-7α-[[(Z)-(2-ホルミルアミノ-4-チアゾリル)(メトキシイミノ)アセチル]アミノ]-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸](/CAS/GIF/66403-32-5.gif) |
(6R,6β)-3-[(アセチルオキシ)メチル]-7α-[[(Z)-(2-ホルミルアミノ-4-チアゾリル)(メトキシイミノ)アセチル]アミノ]-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸 |
66403-32-5 |
C17H17N5O8S2 |
 |
Reference preparation |
|
|
![(2R,4S)-5-(ビフェニル-4-イル)-4-[(3-カルボキシプロピオニル)アミノ]-2-メチルペンタン酸エチルエステル](/CAS/20180808/GIF/761373-05-1.gif) |
(2R,4S)-5-(ビフェニル-4-イル)-4-[(3-カルボキシプロピオニル)アミノ]-2-メチルペンタン酸エチルエステル |
761373-05-1 |
C24H29NO5 |
 |
AcarBose EP Impurity C |
|
|
 |
N-(3-(2-(2-chloropyriMidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonaMide |
1195768-20-7 |
C18H11ClF3N3O3S |
![1-Piperidinepropanenitrile, 4-methyl-β-oxo-3-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, (3R,4R)-](/CAS/20211123/GIF/1527525-58-1.gif) |
1-Piperidinepropanenitrile, 4-methyl-β-oxo-3-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, (3R,4R)- |
1527525-58-1 |
C15H18N6O |
 |
11-monoketofusidic acid |
16711-91-4 |
C31H46O6 |
![(4S,5S)-4-Benzyl-5-[(2S)-2-((4S)-4-isopropyl-2,5-dioxoiMidazolidin-1-yl)-3-phenylpropyl]-2-oxo-1,3-oxazolidine-3-carboxylate thiazol-5-ylMethyl Ester](/CAS/GIF/1010809-43-4.gif) |
(4S,5S)-4-Benzyl-5-[(2S)-2-((4S)-4-isopropyl-2,5-dioxoiMidazolidin-1-yl)-3-phenylpropyl]-2-oxo-1,3-oxazolidine-3-carboxylate thiazol-5-ylMethyl Ester |
1010809-43-4 |
C30H32N4O6S |
 |
Cefprozil EP Impurity I |
|
C18H19N3O5S |
 |
Bortezomib Impurity WQ |
|
|
 |
Deferasirox Impurity 6 |
2254105-61-6 |
C21H15N3O4 |
 |
Peramivir Impurity 32 |
|
|
 |
N,N'-Desethylene-N,N'-diforMyl Levofloxacin |
151377-74-1 |
C18H18FN3O6 |
![6α-[[(4-ヒドロキシベンジル)カルボニル]アミノ]ペニシラン酸](/CAS/GIF/525-91-7.gif) |
6α-[[(4-ヒドロキシベンジル)カルボニル]アミノ]ペニシラン酸 |
525-91-7 |
C16H18N2O5S |
 |
Albendazole EP Impurity J |
946498-41-5 |
C9H7Cl2N3O2 |
 |
Nicorandil Impurity |
|
|
![(3R,5R,7R,8R,9S,10R,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-17-[(]](/CAS/GIF/863-39-8.gif) |
(3R,5R,7R,8R,9S,10R,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-17-[(] |
863-39-8 |
C28H48O5 |
 |
トラボプロスト酸 |
54276-17-4 |
C23H29F3O6 |
 |
ノルダポキセチン |
157166-71-7 |
C20H21NO.ClH |
![3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methylpyrido[1,2-a]pyrimidin-4-one](/CAS/20180601/GIF/766485-15-8.gif) |
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methylpyrido[1,2-a]pyrimidin-4-one |
766485-15-8 |
C23H23FN4O3 |
 |
4-((3-chloro-4-methoxybenzyl)amino)-2-(methylthio)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide |
1364671-62-4 |
C19H19ClN6O2S |
![2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-, (3aR,4R,5R,6aS)-](/CAS/20210111/GIF/1415385-39-5.gif) |
2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-, (3aR,4R,5R,6aS)- |
1415385-39-5 |
C18H19F3O5 |
 |
Clindamycin 3-Phosphate |
28708-34-1 |
C18H34ClN2O8PS |
 |
Posacozole Related Compound 2 |
165115-70-8 |
C11H10F2O2 |
 |
Rasagiline Impurity 2 |
200628-33-7 |
C16H18ClN |
 |
(R)-(-)-MUSCONE |
10403-00-6 |
C16H30O |
 |
Bromhexine EP Impurity E |
1660957-93-6 |
C15H21Br2ClN2 |
![Carbamic acid, N-[3-fluoro-4-(4-morpholinyl)phenyl]-, 1,1-dimethylethyl ester](/CAS/20200611/GIF/952680-48-7.gif) |
Carbamic acid, N-[3-fluoro-4-(4-morpholinyl)phenyl]-, 1,1-dimethylethyl ester |
952680-48-7 |
C15H21FN2O3 |
 |
プレグナ-4,14-ジエン-3,20-ジオン |
24377-08-0 |
C21H28O2 |
 |
2-クロロメチル-4-メトキシ-3,5-ジメチルピリジン1-オキシド |
848694-10-0 |
C9H12ClNO2 |
 |
Vildagliptin IMpurity 2 (Mixture of DiastereoMers) |
1036959-23-5 |
C24H33N5O3 |
 |
テヌイホリシドA |
139726-35-5 |
C31H38O17 |
 |
RebaMipide iMpurity 1 |
100342-53-8 |
C18H15ClN2O2 |
 |
Clindamycin 4-Phosphate |
54887-30-8 |
C18H34ClN2O8PS |
 |
19-Epi FK-506 |
144490-63-1 |
C44H69NO12 |
 |
Peramivir Impurity 6 |
2124296-37-1 |
C15H28N4O4 |
 |
5-ForMyl-2-Methoxy-benzenesulfonaMide |
105764-07-6 |
C8H9NO4S |
![Benzenecarboximidic acid, 4-[3-(aminocarbonyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridin-4-yl]-3-methoxy-, ethyl ester](/CAS/20210305/GIF/2640280-83-5.gif) |
Benzenecarboximidic acid, 4-[3-(aminocarbonyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridin-4-yl]-3-methoxy-, ethyl ester |
2640280-83-5 |
C23H28N4O4 |
 |
Sugammadex Sodium Impurity 36 |
|
|
![(1S,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル](/CAS/GIF/171596-43-3.gif) |
(1S,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル |
171596-43-3 |
C20H18N2O4 |
 |
Pitavastatin Impurity 2 |
1187966-93-3 |
C25H22FNO4 |
![ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate](/CAS2/GIF/536759-91-8.gif) |
ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
536759-91-8 |
C22H20N4O6 |
 |
2-(3-methylbutanoyl)benzoic acid |
152567-80-1 |
C12H14O3 |
 |
AMoxicillin IMpurity M |
|
C16H19N3O5S |
 |
Ozagrel impurity D |
|
|
 |
bortezoMib iMpurity C |
|
|
 |
Lenalidomide Impurity 13 |
874760-71-1 |
C13H13N3O6 |
 |
Solifenacin IMpurity |
1956436-64-8 |
C23H26N2O3 |
 |
N-SucciniMidoxycarbonyl-β-alanine N-SucciniMidyl Ester |
21994-89-8 |
C12H13N3O8 |
![1H-Imidazole-5-carboxylic acid, 1-methyl-4-[methyl[[(5-oxohexyl)amino]carbonyl]amino]-](/CAS/20210111/GIF/84321-40-4.gif) |
1H-Imidazole-5-carboxylic acid, 1-methyl-4-[methyl[[(5-oxohexyl)amino]carbonyl]amino]- |
84321-40-4 |
C13H20N4O4 |
 |
Ergoline-8-methanol, 10-methoxy-1-methyl-, 5-bromo-3-pyridinecarboxylate (ester), (8β)- (9CI) |
192504-81-7 |
C23H24BrN3O3 |
 |
(S,E)-N-(1-((3-methylbut-1-en-1-yl)amino)-1-oxo-3-phenylpropan-2-yl) pyrazine-2-carboxamide |
862895-00-9 |
C19H22N4O2 |
![2-[3-(アミノカルボニル)-4-(2-メチルプロポキシ)フェニル]-4-メチル-5-チアゾールカルボン酸](/CAS/GIF/1239233-86-3.gif) |
2-[3-(アミノカルボニル)-4-(2-メチルプロポキシ)フェニル]-4-メチル-5-チアゾールカルボン酸 |
1239233-86-3 |
C16H18N2O4S |
 |
D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(4-fluorophenyl)-4-(hydroxymethyl)-1-(1H-1,2,4-triazol-1-yl)- |
1978305-26-8 |
C14H16FN3O2 |
 |
1,4-ジヒドロ-2,6-ジメチル-4-(2-ニトロフェニル)ピリジン-3,5-ジカルボン酸ジエチル |
21829-26-5 |
C19H22N2O6 |
 |
3'-Desethoxy-drotaverine |
85475-88-3 |
C22H27NO4 |
 |
(E)-methyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate |
956932-46-0 |
C14H14N2O2 |
 |
アンヒドロサフロールイエローB |
184840-84-4 |
C48H52O26 |
 |
3,17-bis-deacetylvecuronium |
73319-30-9 |
C30H53BrN2O2 |
 |
1-(4-Bromobutyl)-3,4-dihydro-7-hydroxy-2(1H)-quinolinone |
1424857-68-0 |
C13H16BrNO2 |
 |
Atomoxetine Related Compound B (10 mg) (N-Methyl-3-phenyl-3-(m-tolyloxy)propan-1-amine hydrochloride) |
873310-28-2 |
C17H22ClNO |
 |
cefotaxiMe IMpurity F |
|
|
 |
7-ヒドロキシクロモン |
59887-89-7 |
C9H6O3 |
 |
1,2-Bis(piperazin-1-yl)benzene |
1446750-99-7 |
C14H22N4 |
 |
(E)-methyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate |
956932-46-0 |
C14H14N2O2 |
 |
1-(3-ヒドロキシプロピル)-3,7-ジメチルキサンチン |
59413-14-8 |
C10H14N4O3 |
 |
3-(2-ナフタレニルオキシ)-1,2-プロパンジオール |
34646-56-5 |
C13H14O3 |
 |
(S)-2-amino-N-((S)-1-amino-1-oxobutan-2-yl)butanamide hydrochloride |
2432911-41-4 |
C8H17N3O2 |
![(3S,4S,6S,9S)-13-[2-(1-Hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-thiazolylmethyl Ester](/CAS/20180703/GIF/2034136-66-6.gif) |
(3S,4S,6S,9S)-13-[2-(1-Hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-thiazolylmethyl Ester |
2034136-66-6 |
C37H48N6O7S2 |
 |
2-(tert-butylamino)-1-(4-hydroxy-3-methylphenyl)ethan-1-one |
60853-66-9 |
C13H19NO2 |
 |
Empagliflozin impurity 28 (hydroperoxy impurity) |
2452301-14-1 |
C23H27ClO9 |
 |
Brivaracetam Impurity 21 |
63095-60-3 |
C7H12O2 |
 |
uridine 5'-tetraphosphate |
10003-94-8 |
C9H16N2O18P4 |